Clinical Trials in Thoracic Radiation Oncology: As Easy as 1, 2, 3
- 1 November 2014
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 90 (3) , 490-492
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Traditional Phase 1 and 2 Studies in Thoracic Radiation Oncology Should Be AbandonedInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Prediction of Survival by [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer Undergoing Definitive Chemoradiation Therapy: Results of the ACRIN 6668/RTOG 0235 TrialJournal of Clinical Oncology, 2013
- Pulmonary Toxicity in Stage III Non-Small Cell Lung Cancer Patients Treated With High-Dose (74 Gy) 3-Dimensional Conformal Thoracic Radiotherapy and Concurrent Chemotherapy Following Induction Chemotherapy: A Secondary Analysis of Cancer and Leukemia Group B (CALGB) Trial 30105International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410JNCI: Journal of the National Cancer Institute, 2011
- Phase II Study of Cetuximab in Combination With Chemoradiation in Patients With Stage IIIA/B Non–Small-Cell Lung Cancer: RTOG 0324Journal of Clinical Oncology, 2011
- Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trialThe Lancet, 2009
- Using Fluorodeoxyglucose Positron Emission Tomography to Assess Tumor Volume During Radiotherapy for Non–Small-Cell Lung Cancer and Its Potential Impact on Adaptive Dose Escalation and Normal Tissue SparingInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Positron Emission Tomography and Improved Survival in Patients With Lung CancerThe Will Rogers Phenomenon RevisitedArchives of internal medicine (1960), 2008
- N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology groupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991